Information in this section is not peer-reviewed.
Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate
Testimony before House Committee on Foreign Affairs, United States Congress, 2012
Journal of Spirochetal and Tick-Borne Diseases
US HHS Tick-borne Disease Working Group 2018 Report to Congress